# A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia

> **NCT07668180** · PHASE2 · NOT_YET_RECRUITING · sponsor: **HK inno.N Corporation** · enrollment: 100 (estimated)

## Conditions studied

- Sarcopenia in Elderly

## Interventions

- **DRUG:** IN-207907 120 mg
- **DRUG:** IN-207907 240 mg
- **DRUG:** IN-207907 360 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07668180
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668180, "A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07668180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*